Virtual Reality (VR) has emerged as a transformative medium in neuroscience, moving beyond entertainment into a robust tool for experimental manipulation.

This study presents important findings for the understanding of central brain circuits that underlie nociception-induced escape. Using a laser-based nociception assay, chronic neuronal silencing, ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the ...

Sensorineural hearing loss (SNHL) remains a global health challenge with limited regenerative therapeutic options. This ...

Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and des ...

Broadcast Electronics, under new ownership, will introduce an AM transmitter called AMX, highlighting a compact design and ...

Oum Kalthoum, Abdel Halim Hafez, Asmahan, and Mohamed Abdel Wahab were not simply singers who appeared in films. They were, ...

Marks First In-Human Clinical Study Demonstrating the Value of Immuno-Pharmacodynamics in the Assessment of Radioligand Therapy -- Novigenix AI Liquid Biopsy Platform Identifies Immune Activation ...

A new report published this week outlines further details of Apple’s plan to combat the crease. According to TrendForce, two ...

A new study on HgTe nanocrystal photodiodes through CdS passivation and interface control shows new potential for infrared ...

HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, today announced the preclinical poster presentation titled, ...

On April 7, Joanne Wuensch from Citi reduced the price target on Boston Scientific Corp. (NYSE:BSX) from $98 to $87 while ...